A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Investigation

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI40535PMID 20197621PMCID PMC2827955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential p53-Independent Outcomes of p19Arf Loss in Oncogenesis

  2009cited by this paper
• Clinical significance of p53 alterations in surgically treated prostate cancers

  2008cited by this paper
• Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

  2008cited by this paper
• KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations

  2008cited by this paper
• Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis

  2007cited by this paper
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

  2007cited by this paper
• The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Breaking news: high-speed race ends in arrest--how oncogenes induce senescence.

  2007cited by this paper
• Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

  2006cited by this paper
• Identification of a tumour suppressor network opposing nuclear Akt function

  2006cited by this paper
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

  2006cited by this paper
• Small molecule–based reversible reprogramming of cellular lifespan

  2006cited by this paper
• mTOR and cancer: insights into a complex relationship

  2006cited by this paper
• A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN).

  2006cited by this paper
• mTOR and cancer: reason for dancing at the crossroads?

  2006cited by this paper
• Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA

  2006cited by this paper
• Activation of p 53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK 3 CA

  2006cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005cited by this paper
• BRAFE600-associated senescence-like cell cycle arrest of human naevi

  2005cited by this paper
• Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

  2005cited by this paper
• Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

  2005cited by this paper
• Oncogene-induced senescence as an initial barrier in lymphoma development

  2005cited by this paper
• Tumour biology: Senescence in premalignant tumours

  2005cited by this paper
• Suppressing Cancer: The Importance of Being Senescent

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Disruption of the Mouse mTOR Gene Leads to Early Postimplantation Lethality and Prohibits Embryonic Stem Cell Development

  2004cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

  2004cited by this paper
• Pten Dose Dictates Cancer Progression in the Prostate

  2003cited by this paper
• A PCR primer bank for quantitative gene expression analysis.

  2003cited by this paper
• Isolation of polysomal RNA for microarray analysis.

  2003cited by this paper
• Tumor cell senescence in cancer treatment.

  2003cited by this paper
• p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells.

  2002cited by this paper
• An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice

  2001cited by this paper
• Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

  2001cited by this paper
• Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR

  2001cited by this paper
• p19ARF links the tumour suppressor p53 to Ras

  1998cited by this paper
• The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate*

  1998cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

  1998cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• p53 is mutated in a subset of advanced-stage prostate cancers.

  1993cited by this paper

• Balancing the Edge: Phosphatases as Homeostatic Buffers of Oncogenic Kinase Signaling in Cancer

  2026cites this paper
• EZH2 PROTACs outperform catalytic inhibitors in prostate cancer by targeting a methylation-independent function of PRC2

  2026cites this paper
• Eosinophilic Cells in Endometrial Carcinoma as a Predictor of BRAF Mutation: Report of 2 Cases.

  2026cites this paper
• Harnessing p53 for targeted cancer therapy: new advances and future directions

  2025cites this paper
• Targeting immunosenesence promotes clearance of senescent cells

  2025cites this paper
• Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control

  2025cites this paper
• Experimental and network pharmacology certify itraconazole mitigates fluorouracil-induced intestinal damage by inhibiting mTOR-mediated intestinal senescence.

  2025cites this paper
• Genetically Defined Organoid Models Reveal Mechanisms Driving Squamous Cell Neoplastic Evolution and Identify Potential Therapeutic Vulnerabilities

  2025cites this paper
• Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer

  2025cites this paper
• Integrating Senescence and Oxidative Stress in Cardiac Disease

  2025cites this paper
• Senescence in cancer.

  2025cites this paper
• The Inositol-5-Phosphatase SHIP1: Expression, Regulation and Role in Acute Lymphoblastic Leukemia

  2025cites this paper
• Hallmarks of cellular senescence: biology, mechanisms, regulations

  2025cites this paper
• Therapy-induced senescence in prostate cancer: Mechanisms, therapeutic strategies, and clinical implications.

  2025cites this paper
• Regulation of ribosomal gene expression and senescence by a PML-mTOR-RONIN nuclear complex in triple-negative breast cancer

  2025cites this paper
• Molecular Signatures of Cellular Senescence in Cancer: A Critical Review of Prognostic Implications and Therapeutic Opportunities.

  2025cites this paper
• Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy

  2025cites this paper
• Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment

  2024cites this paper
• Cellular senescence in reproduction: a two-edged sword

  2024cites this paper
• Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment

  2024cites this paper
• Pan-cancer characterization of cellular senescence reveals its inter-tumor heterogeneity associated with the tumor microenvironment and prognosis

  2024cites this paper
• Therapeutic strategies targeting cellular senescence for cancer and other diseases

  2024cites this paper
• Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?

  2024cites this paper
• Systematic transcriptomic analysis and temporal modelling of the senescent human fibroblast

  2024cites this paper
• Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?

  2024cites this paper
• The paradox of senescent-marker positive cancer cells: challenges and opportunities

  2024cites this paper
• The Hippo Signaling Pathway Manipulates Cellular Senescence

  2024cites this paper
• Cellular senescence: Neither irreversible nor reversible

  2024cites this paper
• Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway

  2024cites this paper
• Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signaling

  2024cites this paper
• Synthesis, growth inhibitory activity against tumor cells and structure-activity relationship of CGK733 and its analogs.

  2024cites this paper
• Inhibition of PERK mediated UPR acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma.

  2024cites this paper
• PseudoCell: A Multivalued Logical Regulatory Network to Investigate Premature Senescence Dynamics and Heterogeneity

  2024cites this paper
• Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment

  2024cites this paper
• Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

  2024cites this paper
• Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence

  2024cites this paper
• AS1041, a novel derivative of marine natural compound Aspergiolide A, induces senescence of leukemia cells via oxidative stress-induced DNA damage and BCR-ABL degradation.

  2024cites this paper
• RBM4 regulates cellular senescence via miR1244/SERPINE1 axis

  2023cites this paper
• Cellular senescence: a double-edged sword in cancer therapy

  2023cites this paper
• Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.

  2023cites this paper
• Cellular senescence in glioma

  2023cites this paper
• Targeted hyperactivation of AKT through inhibition of ectopic expressed SHIP1 induces cell death in colon carcinoma cells and derived metastases.

  2023cites this paper
• Nuclear PTEN’s Functions in Suppressing Tumorigenesis: Implications for Rare Cancers

  2023cites this paper
• Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells

  2023cites this paper
• VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer

  2023cites this paper
• Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies

  2023influential citation
• Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.

  2023cites this paper
• Biomarkers of aging

  2023cites this paper
• Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies.

  2022cites this paper
• Exploiting senescence for the treatment of cancer

  2022cites this paper
• Role of Senescence in Tumorigenesis and Anticancer Therapy

  2022cites this paper
• Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications

  2022cites this paper
• Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes

  2022cites this paper
• KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis

  2022cites this paper
• Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells.

  2022cites this paper
• The role of cellular senescence and SASP in tumour microenvironment

  2022cites this paper
• Akt: a key transducer in cancer

  2022cites this paper
• Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach

  2022cites this paper
• Cellular senescence: the good, the bad and the unknown

  2022cites this paper
• Age-Related Lysosomal Dysfunctions

  2022cites this paper
• The equilibrium of tumor suppression: DUBs as active regulators of PTEN

  2022cites this paper
• Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.

  2022cites this paper
• Cell Senescence and Central Regulators of Immune Response

  2022cites this paper
• Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection

  2022cites this paper
• Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation

  2022cites this paper
• The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation

  2022cites this paper
• Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

  2021cites this paper
• Autophagy and PTEN in DNA damage-induced senescence.

  2021cites this paper
• Senescence under appraisal: hopes and challenges revisited

  2021cites this paper
• Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation

  2021cites this paper
• Targeting senescent cell clearance: An approach to delay aging and age-associated disorders

  2021cites this paper
• Cellular senescence: Silent operator and therapeutic target in cancer

  2021cites this paper
• Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies.

  2021cites this paper
• The metabolic roots of senescence: mechanisms and opportunities for intervention

  2021cites this paper
• TBX2 controls a proproliferative gene expression program in melanoma

  2021cites this paper
• Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer

  2021cites this paper
• PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells

  2021cites this paper
• The Paradoxical Role of Cellular Senescence in Cancer

  2021cites this paper
• Cellular senescence as a possible link between prostate diseases of the ageing male

  2021cites this paper
• Role of PTEN-less in cardiac injury, hypertrophy and regeneration

  2021cites this paper
• Analysis of the Contribution of NF-κB in the Regulation of Chemotherapy-Induced Cell Senescence by Establishing a Tetracycline-Regulated Cell System.

  2021cites this paper
• The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy.

  2021cites this paper
• Cytokine-Induced Senescence: An Experimental Treatment of Peritoneal Tumors

  2021cites this paper
• CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

  2020cites this paper
• The roles of MTOR and miRNAs in endothelial cell senescence

  2020cites this paper
• Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review

  2020cites this paper
• Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer

  2020cites this paper
• Oncogene-Induced Senescence: from Biology to Therapy.

  2020cites this paper
• Senolytics in Disease, Ageing and Longevity

  2020cites this paper
• Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors

  2020cites this paper
• Cellular Senescence and Tumor Promotion

  2020cites this paper
• Cellular senescence in ageing: from mechanisms to therapeutic opportunities

  2020cites this paper
• Cellular senescence in cancer: from mechanisms to detection

  2020cites this paper
• Targeting senescent cells and tumor therapy (Review)

  2020cites this paper
• Expansion of senescent megakaryocyte-lineage cells maintains CML cell leukemogenesis.

  2020cites this paper
• Correction: Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence

  2020cites this paper
• Role of Ubiquitination in PTEN Cellular Homeostasis and Its Implications in GB Drug Resistance

  2020cites this paper
• Biomarkers in the path from cellular senescence to frailty.

  2020cites this paper
• Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells

  2020cites this paper
• Senescent cells as promising targets to tackle age-related diseases.

  2020cites this paper